E-LIB Suche - Ergebnisse für: Wartel, T. Anh

1

Safety and immunogenicity of the Euvichol-S oral cholera va..:

Song, Katerina Rok ; Chapagain, Ram Hari ; Tamrakar, Dipesh...
The Lancet Global Health. 12 (2024) 5 - p. e826-e837 , 2024

Link: https://doi.org/10.1016/..

2

Heterologous Ad26.COV2.S booster after primary BBIBP-CorV v..:

Muangnoicharoen, Sant ; Wiangcharoen, Rakpong ; Lawpoolsri, Saranath...
Vaccine. 42 (2024) 19 - p. 3999-4010 , 2024

Link: https://doi.org/10.1016/..

3

Single Ad26.COV2.S booster dose following two doses of BBIB..:

Muangnoicharoen, Sant ; Wiangcharoen, Rakpong ; Nanthapisal, Sira...
Vaccine. 41 (2023) 32 - p. 4648-4657 , 2023

Link: https://doi.org/10.1016/..

4

A randomized, observer-blind, controlled phase III clinical..:

Chaudhary, Shipra ; Shah, Gauri Shankar ; Bhatta, Nisha Keshary...
Human Vaccines & Immunotherapeutics. 19 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

5

Hepatitis E vaccine—Illuminating the barriers to use:

Lynch, Julia A. ; Lim, Jacqueline Kyungah ; Asaga, Philomena E. Peter...
PLOS Neglected Tropical Diseases. 17 (2023) 1 - p. e0010969 , 2023

Link: https://doi.org/10.1371/..

6

A Phase 3, Multicenter, Randomized, Controlled Trial to Eva..:

Carlos, Josefina Cadorna ; Tadesse, Birkneh Tilahun ; Borja-Tabora, Charissa...
The Lancet Regional Health - Western Pacific. 24 (2022) - p. 100484 , 2022

Link: https://doi.org/10.1016/..

7

Factors affecting willingness to participate in vaccine cli..:

Chapagain, Ram Hari ; Adhikari, Santosh ; Giri, Bishnu Rath...
Human Vaccines & Immunotherapeutics. 18 (2022) 5 - p. , 2022

Link: https://doi.org/10.1080/..

8

COVID-19 Vaccines Authorized by Stringent Regulatory Author..:

, In: Frontiers of COVID-19,

Sanicas, Melvin ; Wartel, T. Anh ; Sanicas, Merlin - p. 575-594 , 2022

Link: https://doi.org/10.1007/..

9

Safety and immunogenicity of the Vi-DT typhoid conjugate va..:

Kumar Rai, Ganesh ; Saluja, Tarun ; Chaudhary, Shipra...
The Lancet Infectious Diseases. 22 (2022) 4 - p. 529-540 , 2022

Link: https://doi.org/10.1016/..

10

Immune persistence and response to booster dose of Vi-DT va..:

Capeding, Maria Rosario ; Tadesse, Birkneh Tilahun ; Sil, Arijit...
npj Vaccines. 7 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

11

Immune non-interference and safety study of Vi-DT typhoid c..:

Saluja, Tarun ; Rai, Ganesh Kumar ; Chaudhary, Shipra...
Vaccine. 40 (2022) 40 - p. 5828-5834 , 2022

Link: https://doi.org/10.1016/..

12

Acute respiratory distress syndrome (ARDS) as an adverse ev..:

Serazin, Nathan A. ; Edem, Bassey ; Williams, Sarah R....
Vaccine. 39 (2021) 22 - p. 3028-3036 , 2021

Link: https://doi.org/10.1016/..

13

Challenges and opportunities in setting up a phase III vacc..:

Saluja, Tarun ; Giri, Bishnu Rath ; Chaudhary, Shipra...
Human Vaccines & Immunotherapeutics. 17 (2021) 7 - p. 2149-2157 , 2021

Link: https://doi.org/10.1080/..

14

Safety and immunogenicity of Vi-DT conjugate vaccine among ..:

Capeding, Maria Rosario ; Sil, Arijit ; Tadesse, Birkneh Tilahun...
EClinicalMedicine. 27 (2020) - p. 100540 , 2020

Link: https://doi.org/10.1016/..

15

Review on the Recent Advances on Typhoid Vaccine Developmen..:

Syed, Khalid Ali ; Saluja, Tarun ; Cho, Heeyoun...
Clinical Infectious Diseases. 71 (2020) Supplement_2 - p. S141-S150 , 2020

Link: https://doi.org/10.1093/..